Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MRPL32 pseudogene 1 (MRPL32P1) is a non-coding segment of DNA related to the functional MRPL32 gene, which encodes the mitochondrial ribosomal protein L32 and plays a role in mitochondrial ribosome assembly[7][4][5]. However, as a pseudogene, MRPL32P1 does not produce a functional protein or perform any known biological functions. Pseudogenes like MRPL32P1 arise from the duplication or retrotransposition of functional genes but generally accumulate mutations that prevent protein coding. There are no known clinical, therapeutic, or biomarker implications associated with MRPL32P1, and it is not considered a pharmacological or therapeutic target[7][8][4]. MRPL32 (not the pseudogene) encodes a genuine mitochondrial ribosomal protein and is involved in mitochondrial protein synthesis, but MRPL32P1 is only a nonfunctional genomic copy, classified as a pseudogene[1][3][5][7]. If a gene symbol is followed by "P" or described as a pseudogene (e.g., MRPL32P1, RPL32P3), it almost always denotes a nonfunctional element without a therapeutic or diagnostic role[7][10][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MRPL32 pseudogene 1 (MRPL32P1).